跳至主要内容
临床试验/ACTRN12623000926639
ACTRN12623000926639尚未招募Unknown

The effect of a novel nasal mask on minute ventilation in adults with chronic respiratory failure: A pilot randomised cross-over trial.

Fisher & Paykel Healthcare Limited0 个研究点目标入组 15 人开始时间: 2023年8月29日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • A doctor’s diagnosis of a chronic respiratory and/or cardiovascular disease
  • Oxygen saturation measured by pulse oximetry (SpO2) of less than or equal to 90% while breathing room air
  • PtcCO2 greater than or equal to 45mmHg on transcutaneous monitor at baseline measurement

排除标准

  • Age < 18 years
  • Unable to tolerate oxygen saturations on room air if on long term oxygen therapy
  • Evidence of respiratory infection or colonization with multidrug resistant bacteria, Pseudomonas species, Burkholderia Cepacia or mycobacteria
  • Suspected or proven infection with SARS-CoV-2 (COVID-19)
  • Risk of barotrauma, as assessed by the investigator
  • Nasal or facial conditions precluding use of NIV with nasal pillow or oronasal mask
  • Failure of mask fitting test
  • Intracranial trauma or trans-nasal neurosurgery (within 6 weeks)
  • Failure of PulmoVista 500 IET electrode belt fitting (low signal quality, poor skin integrity)
  • Weight <50kg
  • Cardiac pacemaker, an implantable cardioverter-defibrillator (ICD) or any other active implants
  • Self-reported current pregnancy
  • Any other condition which, at the investigator’s discretion, is believed may present a safety risk or impact the feasibility of the study or the study results

研究者

相似试验

A study to investigate the effect of a new nasal... | 临床试验